Envios
Formal Meetings Between The FDA and Biosimilar Biological Product Sponsors or Applicants November 2015 Procedural 15085fnl 0% acharam este documento útilDesignation of Official Names and Proper Names For Certain Biological Products Propose Rule 2015-21382 0% acharam este documento útilBioeqivalence Recommendations For Specific Products 8857fnl PDF 0% acharam este documento útilBioeqivalence Recommendations For Specific Products 8857fnl 0% acharam este documento útilStability Guidance & Draft Q&A Guidance Considerations FDA Small Business WEBINAR 2013-11-04 UCM373234 PDF 0% acharam este documento útilGood ANDA Submission Practices DRAFT January 2018 Generics PDF 0% acharam este documento útilReferencing Approved Drug Products in ANDA Submissions DRAFT 01-2017 Generics PDF 0% acharam este documento útilCDER/OC/OMQ's Role in Inspections and ANDA Review 0% acharam este documento útilRLD - Reference Standard - BOS Draft Guidance Webinar 1-18-17 PDF 0% acharam este documento útil